Literature DB >> 14718581

Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.

V D Awasthi1, D Garcia, R Klipper, B A Goins, W T Phillips.   

Abstract

To prepare long-circulating liposomes, poly(ethylene glycol) (PEG)-lipid is usually mixed with other lipid components before vesicle formation. PEG-lipids can also be postinserted in the outer layer of liposomes after the preparation. In this study, PEG-distearoylphosphatidylethanolamine was incorporated by postinsertion technique into liposome-encapsulated hemoglobin (LEH) carrying neutral or negative charge. Postinsertion technique improved the encapsulation efficiency of hemoglobin from about 0.0017 to 0.017 (hemoglobin/phospholipid, molar ratio) for a similar lipid composition. Thus, neutral, anionic, PEG-neutral, and PEG-anionic LEHs were made and labeled with technetium-99m to follow their biodistribution. A small dose of LEH (approximately 15 mg of phospholipid) was injected intravenously in rabbits, and its distribution was monitored by blood sampling, gamma camera imaging, and tissue radioactivity counting on necropsy. The 24-h blood levels of neutral, PEG-neutral, anionic, and PEG-anionic LEHs were 14, 40.3, 13.1, and 35.7% of injected dose, respectively; calculated T(1/2) values of circulation were 8.9, 19.3, 9.6, and 16.5 h, respectively. PEGylation also influenced accumulation of LEH in the reticuloendothelial system. Liver uptake of neutral LEH dropped from 52.1 to 19.1%, whereas that of anionic LEH came down from 35.3 to 11.5% on PEGylation. In contrast, PEGylation increased the spleen uptake by 8.5- and 2.5-fold for neutral and anionic LEH, respectively. The results demonstrate that PEGylation by postinsertion not only improves the circulation t1/2 of LEH but also enhances hemoglobin content inside the vesicles for better oxygen-carrying capacity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718581     DOI: 10.1124/jpet.103.060228

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging.

Authors:  Jai Woong Seo; Hua Zhang; David L Kukis; Claude F Meares; Katherine W Ferrara
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

2.  Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO.

Authors:  Shahid Rameez; Andre F Palmer
Journal:  Langmuir       Date:  2011-06-16       Impact factor: 3.882

3.  Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

Authors:  Okhil K Nag; Vivek R Yadav; Andria Hedrick; Vibhudutta Awasthi
Journal:  Int J Pharm       Date:  2013-02-16       Impact factor: 5.875

4.  Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin.

Authors:  Vibhudutta Awasthi; Vivek R Yadav; Beth Goins; William T Phillips
Journal:  J Microencapsul       Date:  2012-12-11       Impact factor: 3.142

5.  Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.

Authors:  Hrushikesh Agashe; Kaustuv Sahoo; Pallavi Lagisetty; Vibhudutta Awasthi
Journal:  Colloids Surf B Biointerfaces       Date:  2011-01-25       Impact factor: 5.268

Review 6.  Biosafe nanoscale pharmaceutical adjuvant materials.

Authors:  Shubin Jin; Shengliang Li; Chongxi Wang; Juan Liu; Xiaolong Yang; Paul C Wang; Xin Zhang; Xing-Jie Liang
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

7.  Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

Authors:  M Zouhair Atassi; Catherine Childress
Journal:  Protein J       Date:  2005-01       Impact factor: 2.371

8.  Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock.

Authors:  Vivek R Yadav; Geeta Rao; Hailey Houson; Andria Hedrick; Shanjana Awasthi; Pamela R Roberts; Vibhudutta Awasthi
Journal:  Eur J Pharm Sci       Date:  2016-08-05       Impact factor: 4.384

9.  Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile.

Authors:  Vivek R Yadav; Okhil Nag; Vibhudutta Awasthi
Journal:  Artif Organs       Date:  2014-04-22       Impact factor: 3.094

10.  Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid.

Authors:  Hrushikesh Agashe; Pallavi Lagisetty; Shanjana Awasthi; Vibhudutta Awasthi
Journal:  Colloids Surf B Biointerfaces       Date:  2009-10-14       Impact factor: 5.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.